HIV pre-exposure prophylaxis study finds TAF has higher risk of hypertension than TDF
Researchers at Kaiser Permanente Southern California, Pasadena, have found that in patients taking pre-exposure prophylaxis (PrEP), tenofovir alafenamide fumarate (TAF) use associated with higher incidents of hypertension ...